MannKind Corporation

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $11.7M $174.8M $0 $0 $0 $35.0K $50.0K $93.0K
Cost of Revenue $17.2M $17.1M $64.7M — — — — —
Gross Profit $-5.5M $157.6M $-64.7M — — — — —
Gross Margin -46.7% 90.2% — — — — — —
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $75.0M $46.9M $41.0M $79.4M $59.7M $45.5M $40.6M $40.3M
Operating Income $-108.2M $67.3M $-344.7M $-179.6M $-169.4M $-147.0M $-140.5M $-152.5M
Operating Margin -921.1% 38.5% — — — -419,885.7% -281,078.0% -163,976.3%
Interest Expense $9.5M $15.6M $24.1M $20.4M $21.5M $21.6M $21.8M $17.4M
Pretax Income $-117.3M $125.7M $-368.4M $-198.4M $-191.5M $-169.8M $-160.8M $-170.6M
Income Tax Expense $51.0K $0 $0 $0 $0 $-408.0K — —
Net Income $-117.3M $125.7M $-368.4M $-198.4M $-191.5M $-169.4M $-160.8M $-170.6M
Net Margin -999.0% 71.9% — — — -483,902.9% -321,608.0% -183,397.8%
EPS (Basic) $-1.13 $1.37 $-4.54 $-2.57 $-0.64 $-0.94 $-1.32 $-1.50
EPS (Diluted) $-1.13 $1.36 $-4.54 $-2.57 $-0.64 $-0.94 $-1.32 $-1.50
Shares Outstanding (Basic) 104.2M 92.1M 81.2M 77.0M 369.4M 286.0M 131.5M 127.8M
Shares Outstanding (Diluted) 104.2M 92.1M 81.2M 77.0M 369.4M 286.0M 131.5M 127.8M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 2 Older →